Search

Find exactly what you’re looking for.

Showing 21-38 of 38 results

Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the second quarter of 2023. If you would like to discuss...

NEW YORK, NY, (June 27, 2023) – In joining Saul Ewing as a new partner, Peri Berger will represent clients facing complex commercial disputes involving breach of contract, fraud, business ownership and control, intellectual property, trade secrets and other threats related to their operations in...

In February, 2023, the Antitrust Division of the Department of Justice (“DOJ”) announced they are withdrawing three (3) antitrust policy statements – two of which date from the 1990s – which have been relied upon by healthcare providers and their counsel guiding them through their merger and...

BOSTON (February 22, 2023) – Saul Ewing LLP today announced that Partner Joseph D. Lipchitz has been named Managing Partner of the firm’s Boston office. The Managing Partner is responsible for the office’s budget, internal communications and events, in addition to overseeing the firm’s involvement...

The FTC has announced the annual updates to the Hart-Scott-Rodino (“HSR”) size thresholds, fees and the daily penalty for HSR violations. The updated thresholds and fees were published in the Federal Register on January 26, 2023 and will take effect on February 27, 2023. See Federal Register...

This checklist highlights certain considerations for companies preparing to file annual reports on Form 10-K for calendar year 2022. This list is not intended to be exhaustive and is not a substitute for your understanding of the requirements. It is simply a checklist of items that are new to this...

BACKGROUND: The Rule - What It Means and What It Prohibits A somewhat little-known and obscure provision of U.S. antitrust law – Section 8 of the Clayton Act – makes it illegal in certain circumstances for the same person to serve as a director of competing corporations. If certain conditions exist...

LATEST UPDATE The FTC has voted to extend the public comment period on its proposed rule to ban employers from imposing non-competes on their workers, and will now be accepting comments on the proposed rule until April 19, 2023. Comments can still be submitted in either writing or online using the...

Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...

Gary Lipkin brings more than two decades of legal experience to his new role as a partner in Saul Ewing’s Litigation Department, including handling a diverse range of cases before the nation’s preeminent business court, the Delaware Court of Chancery. He resides in the Firm’s Wilmington office. Mr...

Steven Reingold, a Partner in the firm's Litigation Practice, will participate as a speaker during the Newbie Litigator webinar, hosted by Financial Poise. This webinar discusses procedures and strategies for obtaining temporary restraining orders and preliminary injunctions. The topics discussed...

PRE-LITIGATION BOOTCAMP FOR IN-HOUSE PRACTITIONERS Michael Joyce, a Partner in the Firm's Commercial Litigation practice, will participate as a panelist during an Association of Corporate Counsel webinar. This webinar will cover steps that in-house lawyers can take to minimize and, if necessary...

THE CLASS ACTION MECHANISM, RISKS, AND STRATEGIES TO PROTECT YOUR COMPANY Jon Singer, a Partner in the Firm's Class Actions Practice, will be speaking during the Association of Corporate Counsel's July New to In-House Update. This session will provide a high level overview intended to educate new in...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

People on the Move Gary Lipkin brings more than two decades of legal experience to his new role as a partner in Saul Ewing Arnstein & Lehr’s Litigation Department, including handling a diverse range of cases before the nation’s preeminent business court, the Delaware Court of Chancery. He resides in...

For More Information